Aguirre, S.; Haley, J.K.; Broski, J.A.; Baker, J.; Selby, L.V.; Umar, S.; Al-Kasspooles, M.F.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS): Age-Related Outcomes and a Look into the Future. Cancers 2025, 17, 486.
https://doi.org/10.3390/cancers17030486
AMA Style
Aguirre S, Haley JK, Broski JA, Baker J, Selby LV, Umar S, Al-Kasspooles MF.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS): Age-Related Outcomes and a Look into the Future. Cancers. 2025; 17(3):486.
https://doi.org/10.3390/cancers17030486
Chicago/Turabian Style
Aguirre, Salvador, Jill K. Haley, Julie A. Broski, Jordan Baker, Luke V. Selby, Shahid Umar, and Mazin F. Al-Kasspooles.
2025. "Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS): Age-Related Outcomes and a Look into the Future" Cancers 17, no. 3: 486.
https://doi.org/10.3390/cancers17030486
APA Style
Aguirre, S., Haley, J. K., Broski, J. A., Baker, J., Selby, L. V., Umar, S., & Al-Kasspooles, M. F.
(2025). Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS): Age-Related Outcomes and a Look into the Future. Cancers, 17(3), 486.
https://doi.org/10.3390/cancers17030486
